The pharma industry in the public imagination

July 16, 2013
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ben Adams, image, literary, pharma

Popular culture in both films and literature depict pharma and scientists as part of a nefarious industry, hell bent on …

pfizer image

NICE rejects Pfizer blood cancer drug

July 16, 2013
Sales and Marketing BMS, CML, NICE, Pfizer, bosulif

NICE is not recommending Pfizer’s blood cancer drug Bosulif due to uncertainties over its cost effectiveness and survival benefit. In …

Aesica appoints two new business development managers

July 16, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Aesica, ross, thomas

Contract development and manufacturing organisation Aesica has appointed Sven Thomas and David Ross as business development managers. Under the new …

Irish eyes smiling as Pfizer plans $130m investment

July 15, 2013
Manufacturing and Production IDA, Pfizer, cork, grange

The company has said it will spend $100m upgrading its Grange Castle site in Dublin and $30m at Ringaskiddy in …

lilly image

Lilly revisits Alzheimer’s drug

July 15, 2013
Research and Development, Sales and Marketing Alzheimer's, lilly, solanezumab

Eli Lilly & Co is to run yet another trial of its Alzheimer’s drug solanezumab, which failed twice in Phase …

Roche image

Roche’s Erivedge gains conditional EU approval

July 15, 2013
Sales and Marketing Curis, EU, Erivedge, Roche, Swiss, Zelboraf

Roche’s cancer pill Erivedge has received a conditional European approval for treatment of the most common type of skin cancer. …

J&J image

Next generation digital firms for Europe wanted

July 15, 2013
Medical Communications, Sales and Marketing J&J, JJ, digital, innovation

Digital health start-ups from across Europe are being called on to form a part of Johnson & Johnson Innovation’s inaugural …

simon_lowth_az

Simon Lowth exits AstraZeneca

July 15, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, simon lowth

AstraZeneca’s chief financial officer and executive director Simon Lowth will leave the firm at the end of October. Lowth has …

boehringer_german_building_at_night_5

FDA approves Boehringer’s lung cancer drug

July 12, 2013
Medical Communications, Sales and Marketing Boehringer, FDA, Roche, Tarceva, afatinib, lung cancer

Boehringer Ingelheim’s late-stage lung cancer drug Gilotrif has received an accelerated FDA approval for patients with a certain genetic mutation. …

UK science future looking brighter – survey

July 12, 2013
Research and Development, Sales and Marketing UCB, science

A new survey undertaken by UCB has found that enthusiasm for science in the UK is high, but adds that …

Eliquis image

Eliquis poised for new US approval

July 12, 2013
Sales and Marketing BMS, Bayer, DVT, Eliquis, warfarin

Pfizer and Bristol-Myers Squibb have submitted their oral direct Factor Xa inhibitor Eliquis to the FDA to prevent deep vein …

Eisai image

Eisai backs disease fund

July 12, 2013
Research and Development, Sales and Marketing Eisai, Japan, TB, partnership

A leading Japanese pharma group says that the sector should see investment in fighting diseases of the developing world as …

GSK image

China accuses GSK of large scale bribery

July 12, 2013
Medical Communications, Research and Development, Sales and Marketing Avandia, China, GSK, Seroxat

Health officials in China say they have found evidence GSK tried to generate sales and raise drug prices by bribing …

screen_shot_2013-07-12_at_08

Publicis Life Brands Resolute appoints account director

July 12, 2013
Medical Communications, Sales and Marketing PLBR

Publicis Life Brands Resolute (PLBR) has hired Simon Goldsborough as an account director. Goldsborough brings to the firm over 10 …

wockhardt image

MHRA orders recall of Wockhardt drugs after import ban

July 11, 2013
Manufacturing and Production MHRA, Wockhardt, recall

The UK regulatory authority has asked for a recall of medicines made at a Wockhardt facility in India, shortly after …

Amgen image

Amgen signs Servier deal

July 11, 2013
Sales and Marketing Amgen, Servier, heart, procoloran

Amgen has gained rights in the US to two of Servier’s heart drugs: the novel, oral Procoralan and investigational Phase …

AZ Cambridge

AstraZeneca shores up Cambridge move

July 11, 2013
Research and Development, Sales and Marketing AstraZeneca, Cambridge, research and development

AstraZeneca has cemented its position in Cambridge, the UK location of its purpose-built global HQ from 2016, by signing deals …

Tissue Regenix
 appoints non-executive director

July 11, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing tissue regenix

Regenerative medical devices firm Tissue Regenix has appointed Randeep Singh Grewal as its non-executive
 director of the Group. Grewal has …

Celgene image

NICE no for Celgene’s Revlimid

July 11, 2013
Sales and Marketing Celgene, NICE, Revlimid

NICE has issued new draft guidance not recommending Celgene’s bone marrow disorder drug Revlimid over uncertainties of its efficacy. Revlimid …

The Gateway to Local Adoption Series

Latest content